🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to examine the pre, post, and follow up effect...
Status
Completed
Location
Reno Orthopedic Center
Start Date
2020-11-30
Trial ID
NCT05058209
The investigators hypothesize that washing the insemination catheter prior ...
Status
Terminated
Location
MUHC reproductive center
Start Date
2014-01
Trial ID
NCT02445092
Treatments Being Tested
The primary purpose of the study is to test the efficacy of 2 tablets (twic...
Status
Completed
Location
Site Reference ID/Investigator# 10044
Start Date
2008-09
Trial ID
NCT00763321
This is a single centre, open-label, randomised, single dose, three-period,...
Status
Completed
Location
Simbec Research Ltd.
Start Date
2017-05-22
Trial ID
NCT03178214
Treatments Being Tested
The objective of this study is to investigate the feasibility of cervical T...
Status
Completed
Location
Phoenix Children's Hospital
Start Date
2019-05-21
Trial ID
NCT03859336
Treatments Being Tested
The main reason for this study is to see if Acthar Gel can reduce inflammat...
Status
Terminated
Location
Blue Ocean Clinical Research
Start Date
2018-10-05
Trial ID
NCT03656692
Treatments Being Tested
The investigators propose to conduct this pilot study to evaluate oxytocin ...
Status
Completed
Location
University of North Carolina Chapel Hill
Start Date
2011-03
Trial ID
NCT01308749
This study is to investigate the safety and efficacy of Rotigotine add-on t...
Status
Completed
Location
402
Start Date
2012-10
Trial ID
NCT01723904
Treatments Being Tested
The objective of this study is to evaluate long-term safety of gevokizumab ...
Status
Terminated
Location
Lions Eye Institute
Start Date
2014-08
Trial ID
NCT02375685
Treatments Being Tested
The purpose of this study was to evaluate the efficacy, safety, and tolerab...
Status
Completed
Location
Novartis Investigative Site
Start Date
2021-07-21
Trial ID
NCT04732117
Treatments Being Tested